Efficacy News and Research

RSS
What do we know about the SARS-CoV-2 vaccines so far?

What do we know about the SARS-CoV-2 vaccines so far?

New contraceptive gel contains spermicidal, anti-viral, libido-enhancing agents in one formulation

New contraceptive gel contains spermicidal, anti-viral, libido-enhancing agents in one formulation

Researchers develop new computational method for studying genetic and environmental interactions

Researchers develop new computational method for studying genetic and environmental interactions

Medicinal cannabis improves outcomes in Parkinson's patients

Medicinal cannabis improves outcomes in Parkinson's patients

Flu vaccinations for hospital workers can substantially reduce influenza-related deaths

Flu vaccinations for hospital workers can substantially reduce influenza-related deaths

Novel platform uses modified virus to combat pancreatic cancer

Novel platform uses modified virus to combat pancreatic cancer

Study shows how gut bacteria can dull the efficacy of radiotherapy

Study shows how gut bacteria can dull the efficacy of radiotherapy

Rapid reopening crucial in promoting the second wave of COVID-19

Rapid reopening crucial in promoting the second wave of COVID-19

£1.6 million grant awarded to advance development of MND drug candidate

£1.6 million grant awarded to advance development of MND drug candidate

Moderna vaccine fully neutralizes new SARS-CoV-2 variants, study shows

Moderna vaccine fully neutralizes new SARS-CoV-2 variants, study shows

New discovery could lead to faster and more effective treatments for chronic health complications

New discovery could lead to faster and more effective treatments for chronic health complications

G3BP proteins inhibit metabolic driver that plays a central role in cancers, neurological disorders

G3BP proteins inhibit metabolic driver that plays a central role in cancers, neurological disorders

SARS-CoV-2 rapidly adapts to Vero E6 cell culture propagation

SARS-CoV-2 rapidly adapts to Vero E6 cell culture propagation

Accelerating vaccine rollout may provide greatest reduction in COVID-19 mortality

Accelerating vaccine rollout may provide greatest reduction in COVID-19 mortality

Recombinant SARS-CoV-2 protein vaccine less immunogenic but more antigenic than expected

Recombinant SARS-CoV-2 protein vaccine less immunogenic but more antigenic than expected

B.1.1.7 variant and healthcare workers’ travel worry

B.1.1.7 variant and healthcare workers’ travel worry

Bispecific antibody shows efficacy against new SARS-CoV-2 variants

Bispecific antibody shows efficacy against new SARS-CoV-2 variants

Herd immunity to SARS-CoV-2 may not be achievable with current vaccines

Herd immunity to SARS-CoV-2 may not be achievable with current vaccines

Newly designed Biomesh minimizes postsurgical complications of hernia repair

Newly designed Biomesh minimizes postsurgical complications of hernia repair

Combining anti-tumor antibodies with standard-of-care improves therapeutic outcomes in cancer

Combining anti-tumor antibodies with standard-of-care improves therapeutic outcomes in cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.